FIELD: medicine, oncology. SUBSTANCE: invention proposes to use three-component conjugate consisting of derinate, antibiotic and blood proteins that ensures to deposit anthracycline antibiotics by intramuscular or subcutaneous routes in inactive form. Absence of cardiotoxicity and hematotoxicity ensures to use the proposed method at generalization stage, under stable leukopenia or total severe state of patients. EFFECT: improved method of treatment. 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO TREAT MALE INFERTILITY | 1995 |
|
RU2101017C1 |
| METHOD FOR TREATMENT OF HEMOPOIESIS DISORDERS | 1993 |
|
RU2063228C1 |
| DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
| METHOD OF TREATMENT OF PATIENTS WITH ADVANCED TUMORS OF PERTINEAL CAVITY ORGANS | 1996 |
|
RU2136287C1 |
| ANTIVIRAL IMMUNOTROPIC AGENT | 1999 |
|
RU2158592C1 |
| METHOD FOR TREATMENT OF STOMATITIS | 1992 |
|
RU2018301C1 |
| METHOD OF TREATMENT OF THROMBOOCCLUSION VESSEL DAMAGE | 1992 |
|
RU2020953C1 |
| METHOD OF TREATMENT OF PATIENTS WITH STOMACH AND DUODENAL INTESTINE ULCER DISEASE | 1997 |
|
RU2155591C2 |
| METHOD OF PRODUCING ANTIVIRAL DRUG | 2020 |
|
RU2739186C1 |
| METHOD FOR PREDICTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN WOMEN WITH BREAST CANCER | 2019 |
|
RU2714683C1 |
